General Population Level Estimation for Type 1 Diabetes Risk in Children 0-5 Years Old During Routine Care Delivery

In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.

Sanford Population Level Estimation of Type 1 Diabetes Risk GEnes in Children

Most children with type 1 diabetes (T1D) do not have a family member with diabetes and often are not diagnosed until the child is very sick. Research suggests that screening and identifying children at risk for T1D autoantibodies can prevent serious illness at the time of diagnosis and improve long-term health outcomes. The investigators will screen children, ages 0-5.99 for blood markers related to T1D and celiac disease during routine healthcare delivery at birth, 1, 2 and 5, years of age. Children found to have these markers will be either be referred to clinical care or offered participation in other monitoring or prevention trials.

General Population Level Estimation for Type 1 Diabetes Risk in Children 0-5 Years Old During Routine Care Delivery

Recruitment

Summary

Participation Requirements

Description

Tracking Information